Document is current
Any future updates will be listed below
-
Authors
Valentino, Rebecca R.
Tamvaka, Nikoleta
Heckman, Michael G.
Johnson, Patrick W.
Soto-Beasley, Alexandra I.
Walton, Ronald L.
Koga, Shunsuke
Uitti, Ryan J.
Wszolek, Zbigniew K.
Dickson, Dennis W.
Ross, Owen A. https://orcid.org/0000-0003-4813-756X
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (U54-NS100693)
CurePSP
- License Information
-
More Information
Article History
Received: 12 July 2020
Accepted: 6 September 2020
First Online: 17 September 2020
Ethics approval
: This study was approved by the Mayo Clinic Institutional Review Board and individual written consent was obtained from all participants, or their next of kin, prior to commencement.
: Not applicable.
: ZKW serves as PI or Co-PI on Abbvie, Inc. (M15-562 and M15-563), Biogen, Inc. (228PD201) Grant, and Biohaven Pharmaceuticals, Inc. (BHV4157-206 and BHV3241-301). He serves as PI of the Mayo Clinic American Parkinson Disease Association (APDA) Information and Referral Center, and as Co-PI of the Mayo Clinic APDA Center for Advanced Research. All other authors declare that they have no competing interests.
